Distinguished Scientist, Open Innovation

How will your role help us transform hope into reality?

Blueprint Medicines is seeking a highly motivated, extremely organized, and collaborative Distinguished Scientist, Open Innovation to work in a fast-paced environment across R&D and Business Development.  In this unique role, you will both be a key team member on the Business Development core team and a team leader within Research.  You will work closely with colleagues in Business Development, New Product Planning, Discovery, Translational Sciences, Pharmaceutical Sciences, and Clinical Development to advance internal discovery programs and to evaluate external partnering opportunities.  These activities will impact our therapeutic programs in both Oncology/Hematology and Immunology/Inflammation therapeutic areas.

Want more jobs like this?

Get Science and Engineering jobs in Cambridge, MA delivered to your inbox every week.

Get Jobs

Send me The Muse newsletters for the best in career advice and job search tips.

By signing up, you agree to our Terms of Service & Privacy Policy.

What will you do?

Serve as the lead representative from Research on the Business Development Core Team

• Lead research efforts for all triage activities, drawing on subject matter experts (SMEs) within Research and Development as required
• Participate in all single asset/platform diligence activities, again coordinating SME engagement
• Partner with BD team and New Product Planning to refine our landscape analyses for areas of interest
• Partner with teams who are evaluating potential major academic collaborations, in order to ensure consistency of approach and add scientific/strategic insights
• Act as a key partner to BD Leadership, prioritize BD engagement above other activities

 Serve as a project leader within Research

• Serve as a Project Team Leader (PTL) for at least one program in early phase drug discovery
• As appropriate and the need arises, serve as a PTL for either a Hit-to-Lead or Lead Optimization program
• Advance programs through key decision points, while collaboratively engaging team members and extended team members across R&D

 Engage as a senior leader within Blueprint Research & Development

• Serve as a member of the Science Leadership Team (SLT), and contribute to discussions at regular review meetings within Research
• Actively contribute to the formulation and evolution of our overall scientific portfolio strategy
• More broadly impact the achievement of cross-functional Research goals
• Serve as a mentor for one or more projects that can benefit from mentor engagement

What minimum qualifications do we require?

• Doctoral Degree (MD, PhD) plus 15 years relevant industry experience in both research and early development

What additional qualifications will make you a stronger candidate?

• Extensive project leadership experience in small molecule drug discovery, in both Oncology and Immunology
• Extensive experience with due diligence on external opportunities
• Strong oral and written communication skills, including excellent documentation and organizational skills
• Passion for participating in a fast-paced environment characterized by challenging and rigorous science, and creative thinking
• Strong interpersonal, collaborative, and communication skills; ability to articulate vision, inspire others, and deliver results
• Project leadership experience in additional modalities (e.g., targeted protein degradation, antibodies, RNAi, etc.)
• This is a Cambridge role, although remote applicants will be considered.  If performing this job remotely, then the ideal candidate will be able to on campus at least 4 days/month and as requested to meet special events.
• Effective listening skills and commitment to engaging colleagues with an open-minded approach
• Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

Why Blueprint?

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators – the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

This is the place where the extraordinary becomes reality, and you could be part of it.

Patients are waiting. Are you ready to make the leap?

Equity, Diversity, Inclusion and Affirmative Action

At Blueprint Medicines, we foster a culture of equity, diversity and inclusion.  A proud Equal Employment Opportunity and Affirmative Action employer, we consider all qualified applicants without regard to race, color, sex, gender identity or expression, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable law.  We are also an E-Verify Employer.  We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to [email protected]. 

For more information, please see our EEO-AA Policy Statement, the EEO Know Your Rights Poster, as well as our Pay Transparency Statement. 

Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors.

#LI-Hybrid 

#LI-AQ1